These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 10530636)

  • 1. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial.
    Freeman EW; Rickels K; Sondheimer SJ; Polansky M
    Arch Gen Psychiatry; 1999 Oct; 56(10):932-9. PubMed ID: 10530636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sertraline versus desipramine in the treatment of premenstrual syndrome: an open-label trial.
    Freeman EW; Rickels K; Sondheimer SJ; Wittmaack FM
    J Clin Psychiatry; 1996 Jan; 57(1):7-11. PubMed ID: 8543554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder.
    Freeman EW; Rickels K; Sondheimer SJ; Polansky M; Xiao S
    Am J Psychiatry; 2004 Feb; 161(2):343-51. PubMed ID: 14754784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group.
    Yonkers KA; Halbreich U; Freeman E; Brown C; Endicott J; Frank E; Parry B; Pearlstein T; Severino S; Stout A; Stone A; Harrison W
    JAMA; 1997 Sep; 278(12):983-8. PubMed ID: 9307345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of response to sertraline treatment of severe premenstrual syndromes.
    Freeman EW; Sondheimer SJ; Polansky M; Garcia-Espagna B
    J Clin Psychiatry; 2000 Aug; 61(8):579-84. PubMed ID: 10982201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders.
    Hoehn-Saric R; Ninan P; Black DW; Stahl S; Greist JH; Lydiard B; McElroy S; Zajecka J; Chapman D; Clary C; Harrison W
    Arch Gen Psychiatry; 2000 Jan; 57(1):76-82. PubMed ID: 10632236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venlafaxine in the treatment of premenstrual dysphoric disorder.
    Freeman EW; Rickels K; Yonkers KA; Kunz NR; McPherson M; Upton GV
    Obstet Gynecol; 2001 Nov; 98(5 Pt 1):737-44. PubMed ID: 11704162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo.
    Pearlstein TB; Halbreich U; Batzar ED; Brown CS; Endicott J; Frank E; Freeman EW; Harrison WM; Haskett RF; Stout AL; Yonkers KA
    J Clin Psychiatry; 2000 Feb; 61(2):101-9. PubMed ID: 10732657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome.
    Halbreich U; Smoller JW
    J Clin Psychiatry; 1997 Sep; 58(9):399-402. PubMed ID: 9378691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial.
    Young SA; Hurt PH; Benedek DM; Howard RS
    J Clin Psychiatry; 1998 Feb; 59(2):76-80. PubMed ID: 9501889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies.
    Kornstein SG; Pearlstein TB; Fayyad R; Farfel GM; Gillespie JA
    J Clin Psychiatry; 2006 Oct; 67(10):1624-32. PubMed ID: 17107257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.
    Lydiard RB; Stahl SM; Hertzman M; Harrison WM
    J Clin Psychiatry; 1997 Nov; 58(11):484-91. PubMed ID: 9413414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Full- or half-cycle treatment of severe premenstrual syndrome with a serotonergic antidepressant.
    Freeman EW; Rickels K; Arredondo F; Kao LC; Pollack SE; Sondheimer SJ
    J Clin Psychopharmacol; 1999 Feb; 19(1):3-8. PubMed ID: 9934936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study.
    Jermain DM; Preece CK; Sykes RL; Kuehl TJ; Sulak PJ
    Arch Fam Med; 1999; 8(4):328-32. PubMed ID: 10418540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial.
    Yonkers KA; Kornstein SG; Gueorguieva R; Merry B; Van Steenburgh K; Altemus M
    JAMA Psychiatry; 2015 Oct; 72(10):1037-44. PubMed ID: 26351969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.
    Musselman DL; Somerset WI; Guo Y; Manatunga AK; Porter M; Penna S; Lewison B; Goodkin R; Lawson K; Lawson D; Evans DL; Nemeroff CB
    J Clin Psychiatry; 2006 Feb; 67(2):288-96. PubMed ID: 16566626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allopregnanolone levels and symptom improvement in severe premenstrual syndrome.
    Freeman EW; Frye CA; Rickels K; Martin PA; Smith SS
    J Clin Psychopharmacol; 2002 Oct; 22(5):516-20. PubMed ID: 12352277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Premenstrual dysphoric disorder (PMDD): Drug and psychotherapeutique management, a literature review].
    Marais-Thomas H; Chapelle F; de Vaux-Boitouzet V; Bouvet C
    Encephale; 2024 Apr; 50(2):211-232. PubMed ID: 37821319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind, placebo-controlled pilot study of adjunctive quetiapine SR in the treatment of PMS/PMDD.
    Jackson C; Pearson B; Girdler S; Johnson J; Hamer RM; Killenberg S; Meltzer-Brody S
    Hum Psychopharmacol; 2015 Nov; 30(6):425-34. PubMed ID: 26193781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psychiatric and psychological aspects of premenstrual syndrome].
    Limosin F; Ades J
    Encephale; 2001; 27(6):501-8. PubMed ID: 11865558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.